Next Article in Journal
Novel Genetic and Molecular Pathways in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease
Next Article in Special Issue
Targeting Canonical and Non-Canonical STAT Signaling Pathways in Renal Diseases
Previous Article in Journal
Lymph-Derived Neutrophils Primarily Locate to the Subcapsular and Medullary Sinuses in Resting and Inflamed Lymph Nodes
Previous Article in Special Issue
A Potential Role for HUWE1 in Modulating Cisplatin Sensitivity
Review

The Role of Prostaglandins in Different Types of Cancer

Área de Bioquímica y Biología Molecular, Departamento de Química Inorgánica, Orgánica y Bioquímica, Facultad de Medicina de Albacete/CRIB/Unidad de Biomedicina, Universidad de Castilla-La Mancha/CSIC, C/Almansa 14, 02008 Albacete, Spain
*
Author to whom correspondence should be addressed.
Academic Editors: Stephen Yarwood and Tuula Kallunki
Cells 2021, 10(6), 1487; https://doi.org/10.3390/cells10061487
Received: 11 May 2021 / Revised: 6 June 2021 / Accepted: 9 June 2021 / Published: 13 June 2021
The prostaglandins constitute a family of lipids of 20 carbon atoms that derive from polyunsaturated fatty acids such as arachidonic acid. Traditionally, prostaglandins have been linked to inflammation, female reproductive cycle, vasodilation, or bronchodilator/bronchoconstriction. Recent studies have highlighted the involvement of these lipids in cancer. In this review, existing information on the prostaglandins associated with different types of cancer and the advances related to the potential use of them in neoplasm therapies have been analyzed. We can conclude that the effect of prostaglandins depends on multiple factors, such as the target tissue, their plasma concentration, and the prostaglandin subtype, among others. Prostaglandin D2 (PGD2) seems to hinder tumor progression, while prostaglandin E2 (PGE2) and prostaglandin F2 alpha (PGF) seem to provide greater tumor progression and aggressiveness. However, more studies are needed to determine the role of prostaglandin I2 (PGI2) and prostaglandin J2 (PGJ2) in cancer due to the conflicting data obtained. On the other hand, the use of different NSAIDs (non-steroidal anti-inflammatory drugs), especially those selective of COX-2 (cyclooxygenase 2), could have a crucial role in the fight against different neoplasms, either as prophylaxis or as an adjuvant treatment. In addition, multiple targets, related to the action of prostaglandins on the intracellular signaling pathways that are involved in cancer, have been discovered. Thus, in depth research about the prostaglandins involved in different cancer and the different targets modulated by them, as well as their role in the tumor microenvironment and the immune response, is necessary to obtain better therapeutic tools to fight cancer. View Full-Text
Keywords: prostaglandin; COX-1; COX-2; NSAIDs; cancer prostaglandin; COX-1; COX-2; NSAIDs; cancer
MDPI and ACS Style

Jara-Gutiérrez, Á.; Baladrón, V. The Role of Prostaglandins in Different Types of Cancer. Cells 2021, 10, 1487. https://doi.org/10.3390/cells10061487

AMA Style

Jara-Gutiérrez Á, Baladrón V. The Role of Prostaglandins in Different Types of Cancer. Cells. 2021; 10(6):1487. https://doi.org/10.3390/cells10061487

Chicago/Turabian Style

Jara-Gutiérrez, Álvaro, and Victoriano Baladrón. 2021. "The Role of Prostaglandins in Different Types of Cancer" Cells 10, no. 6: 1487. https://doi.org/10.3390/cells10061487

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop